Bakkali Mustapha El, Aboudrar Souad, Dakka Taoufiq, Benjelloun Halima
Physiology of Exercise Team and Autonomic Nervous System (PET-ANS), Faculty of Medicine and Pharmacy, University Mohammed V-Rabat, Morocco.
Unit of Cardiology A Ibn Sina University Hospital, Rabat 10000, Morocco.
Heliyon. 2020 Jan 18;6(1):e03239. doi: 10.1016/j.heliyon.2020.e03239. eCollection 2020 Jan.
Primary hypertension can be masked and be responsible of a severe impact on the target bodies. The purpose of this study was to see if Phenobarbital at low dose is able to decrease the sympathetic hyperactivity assessed by cardiovascular autonomic reflexes in patients with masked hypertension.
This prospective study was conducted on a total of 91 patients with masked hypertension (average age 52.1 ± 10.3 years old). The cardiovascular autonomic tests performed in this group, before and after 3 months of daily oral administration of Phenobarbital, included deep breathing, hand-grip, mental stress and orthostatic tests. Statistical analysis was done using the Student's t-test, Univariate and Multivariate logistic regression analysis; p is significant if < 0.05.
Cardiovascular autonomic reflexes responses before and after 3 months of Phenobarbital oral administration were as follows: Vagal response (XDB) obtained on deep breathing test was of 32.6 ± 5.4% VS 30.4 ± 6.1%, (p = 0.08), alpha peripheral sympathetic response (alpha SP) obtained on hand grip test was of 35.6 ± 8.7% VS 12.0 ± 2.5%, (p < 0.001), alpha central sympathetic response (alpha SC), beta central sympathetic response (beta SC) obtained during mental stress were of respectively 29.3 ± 9.2% VS 11.8 ± 2.4%, (p < 0.001) and 11.0 ± 5.3% VS 10.4 ± 6.1%, (p = 0.2), alpha peripheral adrenergic sympathetic (alpha PAS) obtained during orthostatic test was of 25.3 ± 6.0% VS 13.0 ± 3.4%, (p < 0.001).
These results demonstrated that Phenobarbital at low dose may have an anti-sympathetic effect in patients with masked hypertension.
原发性高血压可能被掩盖,并对靶器官造成严重影响。本研究的目的是观察低剂量苯巴比妥是否能够降低隐匿性高血压患者通过心血管自主反射评估的交感神经过度活动。
本前瞻性研究共纳入91例隐匿性高血压患者(平均年龄52.1±10.3岁)。该组患者在每日口服苯巴比妥3个月前后进行的心血管自主神经测试包括深呼吸、握力、精神应激和直立试验。采用学生t检验、单因素和多因素逻辑回归分析进行统计分析;p<0.05具有统计学意义。
口服苯巴比妥3个月前后的心血管自主反射反应如下:深呼吸试验获得的迷走神经反应(XDB)为32.6±5.4%对30.4±6.1%,(p=0.08),握力试验获得的α外周交感神经反应(αSP)为35.6±8.7%对12.0±2.5%,(p<0.001),精神应激期间获得的α中枢交感神经反应(αSC)、β中枢交感神经反应(βSC)分别为29.3±9.2%对11.8±2.4%,(p<0.001)和11.0±5.3%对10.4±6.1%,(p=0.2),直立试验期间获得的α外周肾上腺素能交感神经(αPAS)为25.3±6.0%对13.0±3.4%,(p<0.001)。
这些结果表明,低剂量苯巴比妥可能对隐匿性高血压患者具有抗交感神经作用。